Weakness in the ICU: the right weight on the right scale

Nathalie Van Aerde¹, Greet Van den Berghe^{1

2}, Greet Hermans^{3

4}

Affiliations

¹ Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.
² Department of Intensive Care Medicine, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.
³ Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, 3000, Leuven, Belgium. greet.hermans@uzleuven.be.
⁴ Medical Intensive Care Unit, Department of General Internal Medicine, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. greet.hermans@uzleuven.be.

Comment

Nathalie Van Aerde et al. Intensive Care Med. 2021 Jan.

. 2021 Jan;47(1):137-138.

doi: 10.1007/s00134-020-06274-1. Epub 2020 Oct 10.

Nathalie Van Aerde¹, Greet Van den Berghe^{1

2}, Greet Hermans^{3

4}

¹ Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.
² Department of Intensive Care Medicine, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.
³ Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, 3000, Leuven, Belgium. greet.hermans@uzleuven.be.
⁴ Medical Intensive Care Unit, Department of General Internal Medicine, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. greet.hermans@uzleuven.be.

No abstract available

Comment on

Five-year impact of ICU-acquired neuromuscular complications: a prospective, observational study.
Van Aerde N, Meersseman P, Debaveye Y, Wilmer A, Gunst J, Casaer MP, Bruyninckx F, Wouters PJ, Gosselink R, Van den Berghe G, Hermans G. Van Aerde N, et al. Intensive Care Med. 2020 Jun;46(6):1184-1193. doi: 10.1007/s00134-020-05927-5. Epub 2020 Jan 22. Intensive Care Med. 2020. PMID: 31970446
Do ICU-acquired neuromuscular complications impact long-term mortality in general ICU patients?
Okazaki Y, Taito S. Okazaki Y, et al. Intensive Care Med. 2021 Jan;47(1):135-136. doi: 10.1007/s00134-020-05969-9. Epub 2020 Feb 24. Intensive Care Med. 2021. PMID: 32095846 No abstract available.

1. Okazaki Y, Taito S (2020) Do ICU-acquired neuromuscular complications impact long-term mortality in general ICU patients? Intensive Care Med. https://doi.org/10.1007/s00134-020-05969-9 - DOI - PubMed
1. Van Aerde N, Meersseman P, Debaveye Y, Wilmer A, Gunst J, Casaer MP, Bruyninckx F, Wouters PJ, Gosselink R, Van den Berghe G, Hermans G (2020) Five-year impact of ICU-acquired neuromuscular complications: a prospective, observational study. Intensive Care Med 46:1184–1193 - DOI
1. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphael JC, Outin H, Bastuji-Garin S (2002) Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288:2859–2867 - DOI
1. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez D, Seghboyan JM, Constantin JM, Courant P, Lefrant JY, Guerin C, Prat G, Morange S, Roch A (2010) Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 363:1107–1116 - DOI
1. Hermans G, Van Mechelen H, Clerckx B, Vanhullebusch T, Mesotten D, Wilmer A, Casaer MP, Meersseman P, Debaveye Y, Van Cromphaut S, Wouters PJ, Gosselink R, Van den Berghe G (2014) Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J RespirCrit Care Med 190:410–420 - DOI